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Background: ClC-7 is a homodimeric lysosomal chloride transporter important for lysosomal function and bone
degradation.
Results: Altered gating kinetics of one subunit affect the kinetics of the other subunit.
Conclusion: Gating of ClC-7 involves both CLC subunits and requires noncovalent binding of cytoplasmic domains.
Significance:Osteopetrosis and lysosomal storage disease are associated with accelerating mutations in the ClC-7 C terminus
and the contacting intramembrane part.
CLC anion transporters form dimers that function either as
Cl channels or as electrogenic Cl/H exchangers. CLC chan-
nels display twodifferent types of “gates,” “protopore” gates that
openandclose the twoporesof aCLCdimer independentlyof each
other and common gates that act on both pores simultaneously.
ClC-7/Ostm1 is a lysosomal 2Cl/1H exchanger that is slowly
activatedbydepolarization.This gatingprocess isdrastically accel-
erated by many CLCN7mutations underlying human osteopetro-
sis. Making use of some of these mutants, we now investigate
whether slow voltage activation of plasma membrane-targeted
ClC-7/Ostm1 involves protopore or common gates. Voltage acti-
vation of wild-type ClC-7 subunits was accelerated by co-express-
ing an excess of ClC-7 subunits carrying an accelerating mutation
togetherwithapointmutationrendering thesesubunits transport-
deficient. Conversely, voltage activation of a fast ClC-7 mutant
couldbe slowedby co-expressing anexcess of a transport-deficient
mutant. These effects did not depend on whether the accelerating
mutation localized to the transmembrane part or to cytoplasmic
cystathionine--synthase (CBS) domains of ClC-7. Combining
acceleratingmutations in the samesubunit didnot speedupgating
further.NocurrentswereobservedwhenClC-7wastruncatedafter
the last intramembrane helix. Currents and slow gating were
restoredwhen theCterminuswasco-expressedby itself or fused to
the C terminus of the -subunit Ostm1. We conclude that com-
mon gating underlies the slow voltage activation of ClC-7. It
depends on the CBS domain-containing C terminus that does not
require covalent binding to themembrane domain of ClC-7.
The CLC gene family, first identified by the cloning of the
voltage-dependent Cl channel ClC-0 from Torpedo electric
organ (1), not only encodes Cl channels, but also encodes
anion/proton exchangers (2–5). Both CLC Cl channels and
Cl/H exchangers function as homodimers with one ion
translocation pathway per pore, as shown by mutational struc-
ture/function analysis (6–8) and x-ray crystallography of pro-
karyotic and algal CLC proteins (9, 10). Four of the nine mam-
malian CLC proteins associate with distinct small accessory
subunits that display one or two transmembrane domains (11–
13). For instance, the lysosomal 2Cl/1H exchanger ClC-7
requires binding to the type-I transmembrane protein Ostm1
for protein stability and ion transport activity (12, 14).
The ion transport activity of both CLC Cl channels and
Cl/H exchangers can strongly depend on the transmem-
brane voltage. Voltage-dependent gating has been most thor-
oughly studied with the fish ClC-0 Cl channel. Macroscopic
currents and single-channel analysis provided clear evidence
for two distinct gating processes in ClC-0: a fast, depolariza-
tion-activated protopore gate acting independently on each of
the two pores of the dimer and a slow, hyperpolarization-acti-
vated common gate closing both pores simultaneously (15–17).
Likewise, mammalian ClC-1 and ClC-2 display protopore and
common gating, but their time constants and voltage depen-
dences, as well as the low single-channel conductances of these
channels, render the identification and separation of these gat-
ing modes more difficult (18–22). The crystal structure of bac-
terial EcClC-1, together with mutagenesis, showed that a cer-
tain “gating” glutamate, whose side chain protrudes into the ion
translocation pathway, plays a pivotal role in protopore gating
of CLC channels (23) and in Cl/H coupling of CLC exchang-
ers (5), findings that were amply confirmed in other studies
with prokaryotic and eukaryotic CLCs. The structural basis of
common gating is much less understood, but the gating gluta-
mate may also play a role in closing the permeation pathway
after a common rearrangement of both subunits (24, 25). Early
mutagenesis studies have implicated the cystathionine--syn-
thase (CBS)3 domain-containing C terminus of ClC-0 in its* Thisworkwas supported, in part, by grants from theDeutsche Forschungs-
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slow common gating (26), and more recent studies revealed
C-terminal movements during common gating of ClC-0 and
ClC-1 (27, 28). However, mutations in other regions also affect
common gating. For instance, the C212S mutation that totally
abolishes slow gating of ClC-0 (29) involves a residue close to
the extracellular face of the transmembrane segment.
The mammalian CLC Cl/H exchangers (ClC-3 through
ClC-7), which are predominantly expressed in the endosomal-
lysosomal system (30), are strongly voltage-dependent and
mediate measurable ion transport only at positive cytoplasmic
potentials (14, 31–34). As currents mediated by ClC-3 through
ClC-6 respond very quickly to changes in membrane potential,
it is difficult to attribute their voltage dependence either to a
gating process that turns the ion exchange on and off or to an
intrinsic voltage dependence of the exchange process. Using a
plasma membrane-targeted mutant of the lysosomal ClC-7
anion/proton exchanger (35), we recently found that ClC-7/
Ostm1 currents respond very slowly to voltage changes (14).
These slow current relaxations enabled us to show that the
strong outward rectification of ClC-7/Ostm1 is owed to a volt-
age-dependent gating of the 2Cl/1H exchange process that
intrinsically shows an almost linear voltage dependence (14).
Mutations either in ClC-7 or in its -subunit Ostm1 lead to
osteopetrosis, lysosomal storage disease, and neurodegenera-
tion in mice and humans (12, 36–39). Interestingly, several
humanCLCN7mutations identified in osteopetrosis drastically
accelerate the gating of ClC-7/Ostm1, suggesting that slow gat-
ing may be needed for its physiological function (14). Several of
these mutations affect residues in the cytoplasmic CBS
domains or in nearby loops of the membrane part of ClC-7. In
the present work, we use some of these accelerating mutations,
in combination with other mutants and biophysical analysis, to
show that the gating of ClC-7/Ostm1 involves the common
gate. By extension, these findings probably also apply to the
other mammalian 2Cl/1H exchangers in which gating can-
not be studied easily.
EXPERIMENTAL PROCEDURES
Expression Constructs—All constructs for heterologous expres-
sion inXenopus laevis oocytes were cloned into the pTLN expres-
sion vector (40) as described (14). Point mutations, insertions,
and deletions were introduced into human ClC-7 by recombi-
nant PCR. All constructs were confirmed by sequencing the
complete open reading frame. To delete the ClC-7 C terminus,
a stop codon was introduced at position 624 (ClC-7C624X, or
ClC-7CT for short). C-terminal residues 617–805 were either
expressed as a bona fide soluble protein (ClC-7CT) or fused to
the last amino acid of Ostm1 (Ostm1-ClC-7CT).
Voltage Clamp of X. laevis Oocytes—X. laevis oocytes were
injected with cRNA transcribed as described (14) using the
mMESSAGE mMACHINE kit (Ambion) according to the fol-
lowing scheme: WT (wild-type hClC-7)  Ostm1, 23 ng  23
ng; fast gating mutant  Ostm1, 23 ng  23 ng; WT  fast
gating mutant/E314A  Ostm1, 7 ng  28 ng  12 ng; fast
gating mutant  E314A  Ostm1, 7 ng  28 ng  12 ng;
ClC-7CT  Ostm1, 15 ng  15 ng; ClC-7CT  ClC-7CT 
Ostm1, 15 ng 15ng 15ng;ClC-7CTOstm1-ClC-7CT, 23
ng  23 ng; insertion/deletion mutants  Ostm1, 23 ng  23
ng. Oocytes were kept for 3 days at 17 °C before currents were
measured using a two-electrode voltage clamp employing Tur-
boTEC amplifiers (npi electronic GmbH, Tamm, Germany)
and pClamp 10 Software (Molecular Devices). Oocytes were
superfused with ND96 saline (96 mM NaCl, 2 mM potassium
gluconate, 1.8 mM calcium gluconate, 1 mM magnesium gluco-
nate, 5 mM HEPES, pH 7.5). In some experiments, NaCl was
replaced with equimolar amounts of NaNO3. Currents were
evoked by clamping the cells for 2 s to voltages between 80
mV and 80 mV in 20-mV steps followed by a repolarizing step
to 80 mV for 500 ms. Leak and capacitive currents were not
compensated for, but in the figures, capacitive transients were
removed for clarity. Time constants of activation and deactiva-
tion were obtained from monoexponential fits to the current
trace from 25 to 275 ms after the voltage step to 80 mV or to
80 mV following a 2-s pulse to 80 mV, respectively. To deter-
mine relative nitrate conductance, the same oocyte was mea-
sured both in standard ND96 and in ND96 in which Cl was
replaced by NO3. Current amplitudes at 80 mV were normal-
ized to the ones in standard ND96.
RESULTS
As common gating is associatedwith a coordinate conforma-
tional change of both subunits of functional CLCdimers,muta-
tions altering common gating may affect the gating of a wild-
type (WT) subunit when present in just one subunit of a
WT/mutant heteromer. Indeed, CLCN1 mutations identified
in patients with dominant myotonia that shift the voltage of
half-maximal activation (V1⁄2) of homodimeric ClC-1 also
shifted the voltage dependence of WT subunits inWT/mutant
heteromers (41) by changing common gating (18). In a more
extreme case, the slow activation by hyperpolarization of ClC-2
was abolished inClC-1/ClC-2 heterodimeric channels (40).We
therefore argued that human CLCN7 mutations that lead to
faster gating in ClC-7 homodimers (14) should accelerate gat-
ing of WT subunits in WT/mutant heterodimers if the activa-
tion process involves a common gate. However, changed gating
kinetics of different subunits are difficult to disentangle upon
1:1 co-expression ofWT and fastmutant subunits as we have to
dealwith a 1:2:1mixture ofWT/WT,WT/mutant, andmutant/
mutant subunits. One may try to solve this problem by forcing
the formation of heterodimers by constructing concatemers.
Although this approach was successfully applied previously in
mixing CLC subunits of different unitary conductances (6, 8,
42), gating kinetics may easily be changed by linking the C ter-
minus of one subunit to the amino terminus of the second one.
Indeed, a human ClC-7 frameshift mutant (G796fs) (43) that
replaced the last 10 C-terminal residues by 129 foreign ones
accelerated ClC-7 gating (14).
We therefore opted to combine in a single subunit a fast
mutation with another mutation that abolishes ion transport
through the same subunit (see scheme in Fig. 1A). Co-expres-
sion of this virtually fast, but transport-deficient (“td”) mutant
atmolar excess withWT subunits should result in currents that
are dominated by WT subunits present in ClC-7/ClC-7fast,td
heteromers. We used the E314A mutation, which will be fur-
ther referred to as td, to abolishClC-7/Ostm1 transport activity
(14). This mutation neutralizes a “proton glutamate” at the
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cytoplasmic face of the transmembrane part of ClC-7 that is
thought to be required for the transport of cytoplasmic protons
to theCl/H exchange site at the gating glutamate (44).Mam-
malian Cl/H exchangers carrying such proton glutamate
mutations do not measurably transport Cl either (14, 34, 42),
probably because Cl lacks its exchange partner. This mecha-
nism suggests that the block of ion transport is confined to
subunits carrying the td mutation. Although not indicated in
the following text, all ClC-7 subunits additionally carried the
L23A,L24A and L68A,L69A mutations in N-terminal AP- and
GGA-binding sites, respectively, which lead to partial plasma
membrane localization of ClC-7 (14, 35). Furthermore, all con-
structs were co-expressed with the essential -subunit Ostm1
(12, 14).
We first performed several controlmeasurements to validate
our experimental strategy. To confirm that currents of ClC-7/
ClC-7td heteromers were only carried by subunits not contain-
ing the td mutation, we exploited the effect of the pore muta-
tion S204P that selectively increases nitrate conductance (14,
45, 46). Coexpression of ClC-7S204P with amolar excess of ClC-
7td gave rise to currents whose nitrate selectivity was indistin-
guishable from that of ClC-7S204P homomers (Fig. 1B). Hence
the td mutation abolishes currents only in the subunit in which
it has been inserted, and this effect does not require that the
adjacent subunit of the dimer also carries this mutation. In
other control experiments, we ascertained that the tdmutation
abolished ClC-7 transport activity also when present together
with the accelerating mutations R762Q or R286Q in the same
subunit (Fig. 1C).
For our analysis, we chose three previously characterized
(14) fast mutants of ClC-7: R762Q (36) and R767Q (47), muta-
tions in the second CBS domain found in patients with reces-
sive infantile osteopetrosis, and R286Q, which changes a resi-
due in the intracellular loop between intramembrane helices F
and G and that has been found in dominant osteopetrosis (47)
(for localization of these mutations, see Fig. 1, D and E). We
co-injected oocytes with ClC-7 and ClC-7fast,td cRNAs at a 1:4
ratio (Fig. 2). ClC-7 currentswere elicited by 2-s voltage steps to
80 mV. Activation and deactivation kinetics were determined
by fitting single exponential equations to currents at the begin-
ning and at the end of the depolarizing voltage step, respec-
tively. Although present in a transport-deficient ClC-7td sub-
unit, all three fast mutations (R286Q, R762Q, and R767Q)
markedly accelerated the activation kinetics of ClC-7 currents
in trans through the attachedWT subunit in ClC-7/ClC-7td,fast
heteromers. This acceleration did not reach the same levels as
observedwith homomeric ClC-7fast/ClC-7fast transporters (Fig.
2,A–D). However, this apparent difference in kinetics is at least
FIGURE 1. Experimental design and controls. A, schematic presentation of CLC transporter dimers. Eachmonomer contains an ion permeation pathway.WT
subunits are shown inwhite, subunits with an accelerating point mutation are in gray, and subunits carrying a transport-abolishing point mutation (td; E314A
in ClC-7) are symbolized by a lack of the central ”hole.“ From left,WT/WT, fast/fast,WT/fast, andWT/(fast,td) dimers. B, subunits carrying the transport-deficient
tdmutation do not contribute to currents inWT/td heteromers as probed by differences in nitrate selectivity ofWT (round hole) and S204P (square hole) ClC-7
subunits, as indicated by nitrate selectivity of currents that is indistinguishable between S204P/S204P and S204P/td dimers. Thick lines in data point clouds
indicate arithmeticmean, and thin lines indicate S.E. C, representative voltage clamp traces. The tdmutation abolishes currents not only when inserted into
WT subunits, but also when inserted into subunits containing the R286Q (lower left trace) or R762Q (lower right trace) mutations. D, topology model of ClC-7
showing the localization of the fast mutations ClC-7R286Q, ClC-7R762Q, ClC-7R762L, and ClC-7R767Q. All these mutations underlie human osteopetrosis. E, muta-
tions mapped into the crystal structure of algal CmClC. The transmembrane domain is shown in light gray, and the CBS domains are in dark gray. Positions of
the gating (Glu-247 in ClC-7, Glu-210 in CmClC) and proton (Glu-314 in ClC-7, Thr-269 in CmClC) glutamates and of residues Arg-286, Arg-762, and Arg-767 (in
ClC-7, corresponding to Leu-241, Val-680, and Ser-685, respectively, in CmClC) are shown as black spheres, for clarity only in one of the two subunits.
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partially owed to currents fromWTClC-7/ClC-7 homodimers,
which are estimated to contribute about 20% with our 1:4 ClC-
7:ClC-7td,fast co-injection scheme. In the reverse experiment,
we asked whether ClC-7fast currents could be slowed down in
trans by 1:4 co-expression with ClC-7td mutants. This was
indeed the case, and gating kinetics were similar between ClC-
7/ClC-7fast,td and ClC-7fast/ClC-7td expression schemes for all
three acceleratingmutants (Fig. 2,A–D). Likewise, deactivation
kinetics of ClC-7 were accelerated in trans by ClC-7td,fast
mutants (Fig. 2, E–G). In control experiments, ClC-7td did not
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affect gating kinetics of co-injected ClC-7, and ClC-7fast/ClC-
7td,fast displayed gating kinetics similar to ClC-7fast (Fig. 2).
We next asked whether we could further accelerate ClC-7
gating by inserting two fast mutations into the same subunit.
We generated the ClC-7 R286Q,R762Q, R286Q,R767Q, and
R762Q,R767Q double mutants, out of which only ClC-
7R286Q,R762Q gave rise to robust currents (Fig. 3A). Time con-
stants of activation of ClC-7R286Q,R762Q and ClC-7R762Q did
not differ from each other, showing that the effects of these
mutations were not additive (Fig. 3B).
Most mutations accelerating the gating of ClC-7 localize to
the interface between the cytosolic C terminus and transmem-
brane domains, where they are thought to disturb gating-rele-
vant interactions (14). On the other hand, the CBS domain-
containing C terminus of ClC-7 is covalently attached to
intramembrane helix R, which directly coordinates a Cl ion in
the CLC pore through the side chain of a tyrosine close to its N
terminus (9). It is tempting to speculate that the ClC-7 C ter-
minus influences gating by changing the position of the R-helix.
We therefore asked whether the length of the R-CBS1-linker
might influence ClC-7 gating. Both deletion and insertion of
several amino acids after threonine 621 (Fig. 4A) indeed accel-
erated gating, whereas deleting 6 amino acids abolished ClC-7/
Ostm1 transport function (Fig. 4, B and C).
These results seemed to support the hypothesis that CBS
domains modulate gating by “pulling” on the R-helix. We were
curious to know what would happen if we entirely eliminated
this possibility by disrupting the peptide bond between helix R
andCBS1, using a “split transporter” approach akin to the “split
channel” approach as used first with the ClC-1 Cl channel
(48). Expression of a ClC-7 mutant truncated shortly after the
R-helix and thus lacking both CBS domains (ClC-7CT) did not
yield currents (Fig. 5, A and B).
Surprisingly, currents of ClC-7CT could be rescued by co-
expressing the cytoplasmic C terminus (ClC-7CT) from a sepa-
rate cRNA (Fig. 5, A and B). Resulting currents reached ampli-
tudes similar to WT ClC-7, but their activation kinetics were
slightly faster (Fig. 5, B and C). Instead of expressing the C
terminus only as a soluble protein, we also fused it to the obli-
gate ClC-7 -subunit Ostm1 directly after its last residue to
anchor it to the plasmamembrane in close vicinity to the ClC-7
backbone. Co-expressing this fusion protein (Ostm1-ClC-7CT)
with ClC-7CT (without additional WT Ostm1) yielded cur-
rents that were indistinguishable from WT ClC-7/Ostm1 in
their kinetics (Fig. 5C) and often reached similar amplitudes.
We also inserted the fast R762L mutation into CBS2 of the
isolated C terminus ClC-7CT and into the Ostm1-ClC-7CT
fusion protein. Although the combination of ClC-7CT ClC-
7CT(R762L) failed to yield currents (data not shown), split chan-
nels in which the mutant C terminus was attached to Ostm1
(ClC-7CTOstm1-ClC-7CT(R762L)) produced robust currents
that displayed activation time constants indistinguishable from
the fast mutant ClC-7R762L  Ostm1 (Fig. 5C). We conclude
that the role of the ClC-7 C terminus in ClC-7 gating does not
depend on a covalent linkage to the last intramembrane helix R.
In view of these results, we re-examined the effects of linker
deletions (Fig. 4) and expressed split transporters in which the
polypeptide chain following helix R was truncated at different
positions (Fig. 5D). These experiments revealed that gating
kinetics became significantly faster when ClC-7 was truncated
at position 621 or earlier. Hence the results of our linker short-
ening might be owed to specific effects of deleting particular
FIGURE 2.Gating kinetics of ion flux through aClC-7monomer are influencedby the adjacent subunit of the dimer. A, effect of the fast R762Qmutation
that affects a residue in the second CBS domain. Original voltage clamp traces fromoocytes injectedwith RNA encodingWTClC-7, ClC-7R762Q, a 1:4 ratio ofWT
and ClC-7R762Q,E314A RNA, and a 1:4 co-injection of the fast ClC-7R762Q mutant with the E314A (td) mutant that renders the subunit transport-deficient are
shown. The voltage clamp protocol is as in Fig. 1. Symbols above diagrams are as follows: WT subunits are shown inwhite, subunits with an accelerating point
mutationare ingray, and subunits carryinga transport-abolishingpointmutation (td; E314A inClC-7) are symbolizedbya lackof the central ”hole.“B, individual
and averaged activation time constants (act) obtained from experiments as shown above. Note that transport-deficient fast subunit accelerates gating in
dimers with aWT subunit and that the transport-deficientWT subunit slows gating in dimers with a fast subunit, resulting in indistinguishable gating kinetics.
C andD, similar experiments obtainedwith R767Q, another acceleratingmutant in CBS2 (D), andwith the fast R286Qmutation at the intracellular side of helix
G of themembrane part of ClC-7 (D). E, individual and averaged deactivation time constants (deact) of the investigated fast mutant ClC-7R762Q. F andG, similar
experiment for ClC-7R767Q (F) and ClC-7R286Q (G). Oocytes in E–G were the same as used in B–D. In all experiments, mRNA for the -subunit Ostm1 was
co-injected. Thick lines indicate arithmetic mean and thin lines indicate S.E. *** indicates a p value 0.001 calculated by Student’s t test between WT and
WT(fast,td), and between fast and tdfast.
FIGURE 3. Insertion of two fastmutations into the same subunit does not
accelerate gating further. A, original recordings of homodimeric ClC-7
transporters containing the fast mutations R286Q (in the transmembrane
domain), R762Q (in CBS2), and R286Q,R762Q double mutants in comparison
with wild-type ClC-7. The voltage clamp protocol is as in Fig. 1. B, individual
and averaged activation time constants (act) obtained from those experi-
ments. Thick lines indicate arithmetic mean, and thin lines indicate S.E. The
-subunit Ostm1 was always co-expressed.
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FIGURE 4. ClC-7/Ostm1 activation kinetics depend on the length of the linker between the transmembrane domain and CBS1. A, diagram showing the
sequence of the linker between the last intramembrane helix R and CBS1. Deletion and insertion constructs are shown. B, typical two-electrode voltage clamp
traces obtainedwith these constructs upon co-expressionwithOstm1.C, evaluation of corresponding activation (act) and deactivation (deact) time constants.
The voltage clamp protocol is as in Fig. 1. Thick lines indicate arithmetic mean, and thin lines indicate S.E.
FIGURE 5. The ClC-7 C terminus is crucial for ClC-7 function and can be supplied as a separate polypeptide chain. A, typical recordings of oocytes
expressing ClC-7CT in which ClC-7 is truncated shortly after the last membrane helix and of oocytes co-expressing this mutant with either the C terminus
(ClC-7CT) or a chimeric protein (Ostm1-ClC-7CT) inwhich the C terminus is fused to the-subunit Ostm1.WTOstm1was co-expressed in the first two cases. The
voltage clamp protocol is as in Fig. 1. B, mean near steady-state current-voltage relationships (evaluated at 2 s after voltage steps) obtained from truncated
constructs comparedwith controls.C, activation timeconstants (act) of currents fromexperiments as above, and fromClC-7CTOstm1-ClC-7CT-R762L inwhich
a ClC-7 C terminus carrying the fast mutation R762L in CBS2 is fused to the Ostm1 -subunit. D, activation time constants of WT ClC-7 compared with split
transporters inwhich the truncationpoint after helix R is varied. ClC-71–623 corresponds toClC-7CT. Constructswerealways co-expressedwithClC-7CT andwith
Ostm1. Thick lines indicate arithmetic mean, and thin lines indicate S.E. Significance levels (one-way analysis of variance): ***, p 0.001.
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amino acids, although the mechanism by which this changes
gating remains unclear.
DISCUSSION
A fascinating aspect of the CLC family is that its members
transport ions in modes traditionally thought to be radically
different; they function either as ion channels or as strictly cou-
pled ion exchangers. However, remnants of an ion exchange
activity can be found inCLCCl channels because the gating of
ClC-0 may be associated with H transport (49). Further, the
strong voltage dependence of Cl/H exchange activity of
vesicular CLCs resembles the gating of ion channels, as recently
demonstrated for plasma membrane-expressed ClC-7 (14).
The intrinsically almost linear anion/proton exchange activity
of this transporter is very slowly turned on by depolarization in
a process that strongly resembles gating of ion channels.
We now asked whether the gating of ClC-7/Ostm1 resem-
bles the ClC-0 protopore gate, which affects one pore at a time,
or its common gate, which closes both pores of the double-
barreled channel simultaneously. We argued that mutations
accelerating ClC-7 gating might impose their faster gating
kinetics on associated WT subunits in heterodimers if the gat-
ing process involves both subunits. We devised experiments in
which one of the subunits of the dimer was rendered transport-
deficient by another mutation to better isolate the effect on the
currents of the other subunit. Such transport-deficientmutants
indeed partially imposed their gating kinetics on the other, trans-
porting subunit, rendering their activation and deactivation faster
or slower, depending on the particular combination. These results
resemble previous work in which dominant ClC-1 mutants par-
tially imposed their shifted voltage dependence (as observed in
homomeric channels) on the gating of heteromers through an
effect on common gating (18, 41). We conclude that voltage-de-
pendent activation of ClC-7/Ostm1 prominently involves com-
mon gating of both subunits. A minor contribution of protopore
gating, however, cannot be excluded.
Many accelerating mutations cluster in cytoplasmic CBS
domains and the cytoplasmic surface of the ClC-7 transmem-
brane segment (14), suggesting that interactions between these
parts of the protein influence gating. We have also explored
another possible mechanism by which mutations in the C ter-
minus could affect gating, i.e. through a direct “pull” of the C
terminus on the last intramembrane helix R. This speculation is
attractive because the N-terminal part of helix R participates in
coordinating a Cl ion in a binding site in the permeation path-
way as revealed by crystal structures of prokaryotic CLCs (9,
23). Consistent with this idea, Förster resonance energy trans-
fer (FRET) experiments using ClC-0 and ClC-1 to whose C
termini GFP variants had been fused indicated large move-
ments of those domains during gating (27, 28). Although initial
experiments in which we varied the length of the R helix-CBS1
linker seemed to support this hypothesis, our subsequent split
transporter experiments clearly indicated that this is not the
case.
These split transporter experiments indicated that the ClC-7
C terminus binds efficiently to the ClC-7 backbone even with-
out being anchored nearby at the plasma membrane (as in the
Ostm1-ClC-7CT fusion protein). The crystal structure of the
CBS domain-containing algal CLC (10) suggests that this bind-
ing prominently involves CBS2, a domain in which several
osteopetrosis-causing mutations were found (14, 36, 43, 47).
The similar gating kinetics of currents obtained from WT and
ClC-7CT co-expressed with either Ostm1-ClC-7CT or the
detached C terminus ClC-7CT suggest that the C terminus does
not fully dissociate from the ClC-7 backbone during gating
because its dilution in the cytoplasm is expected to severely
slow down its reassociation. This should then be accompanied
by a severe deceleration of either activation or deactivation,
depending onwhether the binding of theC terminus “closes” or
“opens” the transporter, respectively. Interestingly, when we
inserted fast mutations into CBS2, we observed functional split
transporters onlywhen themutatedC terminuswas attached to
Ostm1 (Fig. 5C), but not when it was supplied as a soluble pro-
tein. Hence these mutations may destabilize the binding of the
C terminus to the transporter backbone with reasonably effi-
cient binding occurring only when the local concentration of
the C terminus is drastically increased by tethering it to Ostm1.
Split channel (respectively, transporter) approaches have
been used previously with ClC-0 (50), ClC-1 (48, 51–54), and
ClC-5 (55). These studies agreed in that the function of CLC
proteins that were truncated after CBS1 could be rescued by
co-expressing the missing fragment containing CBS2. This
complementation can be easily explained by the tight CBS1-
CBS2 binding that was revealed by crystal structures of CLCCBS
domains (10, 56). Indeed, CBS domains also form internal dimers
in other CBS domain-containing proteins (57). A complementa-
tion similar to theonedescribedhere, i.e. the functional rescueof a
CLC truncated directly after the R helix by the complete soluble C
terminus, had been tried previously with the skeletal muscle Cl
channel ClC-1 (48, 54). However, both studies agreed that the co-
expression of both fragments failed to yield functional channels.
Hence the binding affinity of the backbone to the C-terminal tail
seems to be stronger in the case of ClC-7.
Common gating requires a coordinate conformational
change of both subunits of the dimer that ultimately leads to an
occlusion of the permeation pathway. This necessitates both
changes at the interface between both subunits and of residues
in the pore region. CLCmonomers contact each other not only
at their broad membrane-embedded interface (9, 10), but also
between the CBS domains of either subunit (10, 58). Consistent
with these considerations, FRET detected large movements of
CBS domains during common gating of ClC-0 (27), 19F NMR
indicated substrate-driven changes in the position of a tyrosine
at the membrane-embedded dimer interface of EcClC-1 (59),
and mutations in the gating glutamate in the pore abolish both
common and protopore gating of e.g. ClC-2 (21). However, our
picture of common gating remains appallingly incomplete. In
particular, the way in which mutations in CBS domains affect
this gating process remains enigmatic.
Manymutations, not just those found in patients with osteo-
petrosis, accelerate ClC-7 gating, whereas we have not yet
obtained ClC-7 mutants that gate more slowly thanWT.4 Evo-
lution may have maximized the time constant of ClC-7 gating
4 C. F. Ludwig, F. Ullrich, L. Leisle, T. Stauber, and T. J. Jentsch, unpublished
data.
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that is several orders of magnitude slower than with ClC-3 to
ClC-6. Together with the fact that many disease-causingmuta-
tions accelerate ClC-7 gating (14), these observations suggest
that slow gating of ClC-7 may be important for its biological
function. If accelerated gating by itself were pathogenic, the
acceleration of common gating in WT/fast heteromers might
contribute to the dominant inheritance pattern of some osteo-
petrosis-causing CLCN7mutations. However, some accelerat-
ingmutationsmay also decrease protein stability, as shownpre-
viously (36) for the R762Q mutant we have studied here.
Indeed, this particular accelerating mutation was found in a
patient with recessive osteopetrosis (36).
In summary, the gating of ClC-7/Ostm1 bears parallels to the
common, slow gate of the Torpedo Cl channel ClC-0 that
affects both pores of the dimeric channel simultaneously. It
depends on the presence of the CBS domain-containing C ter-
minus that interacts with the transmembrane backbone and
modulates gating kinetics even in the absence of a covalent link.
Our work extends the role of common gating from CLC Cl
channels to Cl/H exchangers.
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